Which patient population is most at risk for Enterococcus urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Enterococcus UTI: High-Risk Populations

Enterococcal urinary tract infections predominantly occur in hospitalized patients with urinary catheters, recent antibiotic exposure, and urological abnormalities—particularly older males with obstructive uropathy or urinary retention.

Primary At-Risk Populations

The highest-risk patients for enterococcal UTI include 1, 2, 3:

Healthcare-Associated Risk Factors

  • Catheterized patients (59.3% of enterococcal UTI cases) 1
  • Recent antibiotic use within 3 months (51.8% of cases) 1
  • Hospitalized patients, particularly in non-ICU wards (66.4%) 1
  • Nosocomial infection setting (independent predictor) 3

Patient Demographics

  • Male gender is an independent risk factor 2, 3
  • Age 55-75 years represents peak risk 2
  • Older adults (median age 61 years) 1
  • Females still comprise 56.8% of cases overall, but males have disproportionately higher risk 1

Urological Factors

  • Obstructive uropathy (independent predictor) 3
  • Urinary retention 2
  • Previous urinary instrumentation (OR 2.16) 4
  • Indwelling urinary catheter (OR 2.05) 4
  • Nephrostomy tubes 3
  • Urological cancers 3

Special Considerations by Species

E. faecalis (77.3% of enterococcal UTIs) versus E. faecium (22.7%) show distinct patterns 1:

  • E. faecium causes more severe disease with:
    • Higher mortality (23% vs. 10.1%, p=0.002)
    • Longer hospital stays (25 vs. 11.5 days, p<0.001)
    • Greater antibiotic resistance
    • Higher inflammatory markers (CRP 26.7 vs. 13 mg/dL)

Age-Specific Patterns in Males

In male outpatients, enterococcal UTI shows unique epidemiology 5:

  • Young men (18-29 years) have 17% prevalence of E. faecalis in suspected UTI
  • Recurrence rates increase with age: 12% (18-29 years) to 28% (≥70 years)
  • Ciprofloxacin resistance rises with age: 22% (18-29 years) to 37% (≥70 years)
  • E. faecalis is the second most common pathogen (16%) in male outpatient UTI

Clinical Implications for Risk Stratification

When to suspect enterococcal UTI:

  1. Complicated UTI in older males with catheters or recent instrumentation 4
  2. Healthcare-associated infections with prior antibiotic exposure 3
  3. Polymicrobial infections (E. faecalis isolated in 47% of polymicrobial UTIs in men) 5
  4. Immunocompromised patients with severe comorbidities 3

Important caveat: In pediatric patients with high-risk urological factors (CAKUT), enterococcal UTI is uncommon when nitrites are positive (only 1 of 24 cases), suggesting anti-enterococcal coverage may be unnecessary in this specific scenario 6.

Mortality Risk Factors

When enterococcal UTI occurs, mortality (16.5% overall) is associated with 3:

  • SOFA score >4
  • Immunosuppression
  • Malignant hematologic disease
  • E. faecium species (vs. E. faecalis)
  • Ampicillin or vancomycin resistance

The combination of male gender, catheterization, recent antibiotics, and urological obstruction creates the highest-risk profile requiring empiric anti-enterococcal coverage 7, 2.

Related Questions

What is a good empiric therapy for an elderly female patient with a urinary tract infection caused by Enterococcus faecalis and E. coli, and a rising C-reactive protein level?
What is the best treatment for Enterococcus faecalis (E. faecalis) urinary tract infection (UTI)?
Should an elderly patient with lower urinary tract symptoms and a urine culture positive for Enterococcus faecalis be treated even in the absence of pyuria?
What is the recommended treatment for a male patient with a urinary tract infection (UTI) caused by Enterococcus faecalis?
In a 4-year-old child with facial edema, urinary tract infection, nephrotic-range proteinuria (urine protein‑to‑creatinine ratio 2.1 g/g) and severe thrombocytopenia, what is the recommended urgent evaluation and management?
How should I manage a patient on ciprofloxacin who develops leukopenia and lymphadenopathy?
What ICU medications should a new ICU nurse learn, including their mechanisms of action, indications, contraindications, and administration guidelines?
In a 65-year-old man with end-stage renal disease on peritoneal dialysis, heart failure, and diabetes, is the regimen of metolazone 10 mg daily, spironolactone 25 mg daily, and torsemide 20 mg twice daily appropriate?
How should I manage an elderly female patient on 100 µg levothyroxine daily who has an elevated TSH of 7.28 mIU/L with normal T3 and T4?
Is Enterococcus the same as Streptococcus?
Can a 60-year-old patient with severe chronic pain safely take 20 mg of oral oxycodone daily for four years if they do not misuse the medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.